Biotech | February 25, 2022
Biohaven licenses Taldefgrobep Alfa from Bristol Myers Squibb
It is a Phase 3 ready anti-myostatin adnectin for Spinal Muscular Atrophy (SMA).
It is a Phase 3 ready anti-myostatin adnectin for Spinal Muscular Atrophy (SMA).
Methodology developed by QIMR Berghofer researchers utilizing the Agilent Cary 630 FTIR
As part of its on-going work to track variants, WHO's Technical Advisory Group on SARS-CoV-2 Virus Evolution (TAG-VE) discussed the latest evidence on the Omicron variant of concern
Haleon will have a portfolio of category-leading brands including Sensodyne, Voltaren, Panadol and Centrum
DR devices today should do more than just provide crystal clear imaging and assist during diagnosis. Hence, the ImageView Software used in DRX Compass offers upgraded cybersecurity
The SureSTART consumables portfolio is designed for higher performance requirements, while meeting customer budgets
The COVID-19 pandemic has triggered the rapid growth of the biotherapeutics market
Essential products manufactured by Sartorius, using Sü dpack polymer films made from Dow resins, support safe and effective vaccine production for global vaccine supply
The researchers are of the view that the new drug designing strategy demonstrated by them could also be adopted to treat retroviral infections.
The facility will cater to the storage, handling and transportation of pharma, dairy products seafood among others
Subscribe To Our Newsletter & Stay Updated
